Financial

News

Merck sees big lift in Keytruda sales, as Senate probes its ...

Merck & Co has reported record sales of its cancer immunotherapy Keytruda in the second quarter, as members of the Senate Finance Committee continue an investigation into the way the co

News

Dupixent drives Sanofi to hike its full-year profit forecast...

Dupixent's march towards becoming one of the world's top-selling medicines continued at a healthy lick in the second quarter, allowing Sanofi to raise its full-year earnings forecasts.

News

Opdualag off to a flying start, says BMS CEO

Bristol-Myers Squibb's new immune checkpoint inhibitor combination Opdualag has only been on the US market for a few weeks but is already off to a "great start", according to chief executiv

News

Record Shingrix sales help GSK raise 2022 forecasts

In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shin

News

Teva closes on $4.25bn deal to settle US-wide opioid litigat...

Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid cr

News

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

Merck sees big lift in Keytruda sales, as Senate probes its ...

Dupixent drives Sanofi to hike its full-year profit forecast...

Opdualag off to a flying start, says BMS CEO

Record Shingrix sales help GSK raise 2022 forecasts

Teva closes on $4.25bn deal to settle US-wide opioid litigat...

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

AZ claims another win for Imfinzi in frontline liver cancer

Using AI-driven synthetic personas to take your insights fur...

Financial

Editor's Picks